Growth inhibition and induction of differentiation by panaxydol in rat C6 glioma cells

Neurological Research

Volumn 30, Issue 1, 2008, Pages 99-105

  Hai, Jian ^a   Lin, Qi ^b   Lu, Yang ^b   Yi, Jing ^b   Zhang, Hao ^a  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

C6 glioma cell; Cellular differentiation; Glial fibrillary acidic protein; Growth inhibition; p27; Panaxydol

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; EOSIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; PANAZYDOL; PLANT EXTRACT; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FLOW CYTOMETRY; GLIOMA CELL; GROWTH INHIBITION; IC 50; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SIZE; DIYNES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FATTY ALCOHOLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

EID: 44449130430     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X228697     Document Type: Article

References (31)

1. Lin Q, Zhao X, Lu Y, et al. Study on the lipophilic constituents of Panax notoginseng. Chin Trad Herb Drugs 2002; 33: 490-492
2. Lee SH, Hwang WI. Inhibitory effect of petroleum ether extract of Panax ginseng root against growth of human cancer cells. Korean J Ginseng Sci 1986; 10: 141-150
3. Matsunaga H, Katano M, Yamamoto H, et al. Cytotoxic activity of polyacetylene compounds in Panax ginseng C. A. Meyer. Chem Pharm Bull (Tokyo) 1990; 12: 3480-3482
4. Sohn J, Lee CH, Chung DJ, et al. Effect of petroleum ether extract of Panax ginseng roots on proliferation and cell cycle progression of human renal cell carcinoma cells. Exp Mol Med 1998; 30: 47-51
5. Moon J, Yu SJ, Kim HS, et al. Induction of G(1) cell cycle arrest and p27(KIP1) increase by panaxydol isolated from Panax ginseng. Biochem Pharmacol 2000; 59: 1109-1116
6. Shirsat NV, Kayal JJ, Shaikh S, et al. Growth inhibition and differentiation of C6 glioma cells on treatment with HMBA. Cell Biol Int 2001; 25: 621-627
7. Sasaki T, Yamazaki K, Yamori T, et al. Inhibition of proliferation and induction of differentiation of glioma cells with Datura stramonium agglutinin. Br J Cancer 2002; 87: 918-923
8. Nie BM, Yang LM, Fu SL, et al. Protective effect of panaxydol and panaxydol on sodium nitroprusside-induced apoptosis in cortical neurons. Chem Biol Interact 2006; 160: 225-231
9. Wang ZJ, Nie BM, Chen HZ, et al. Panaxynol induces neurite outgrowth in PC12D cells via cAMP- and MAP kinase-dependent mechanisms. Chem Biol Interact 2006; 159: 58-64
10. Parker KK, Norenberg MD, Vernadakis A. "Transdifferentiation" of C6 glial cells in culture. Science 1980; 208: 179-181
11. Nakagawa M, Nakashima S, Banno Y, et al. Increased expression and secretion of r-Gsp protein, rat counterpart of complement C1s precursor, during cyclic AMP-induced differentiation in rat C6 glioma cells. Brain Res Mol Brain Res 2002; 106: 12-21
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
13. Rutka JT, Smith SL. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: Analysis of expression, proliferation, and tumorigenicity. Cancer Res 1993; 53: 3624-3631
14. Rutka JT, Hubbard SL, Fukuyama K, et al. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells. Cancer Res 1994; 54: 3267-3272
15. Engelhard HH, Duncan HA, Dal Canto MD. Molecular characterization of glioblastoma cell differentiation. Neurosurgery 1997; 41: 886-897
16. Takanaga H, Yoshitake T, Hara S, et al. cAMP-induced astrocytic differentiation of C6 glioma cells is mediated by autocrine interleukin-6. J Biol Chem 2004; 279: 15441-15447
17. WAF1/CIP1 induces cell differentiation and growth inhibition in a human glioma cell line. Int J Cancer 1998; 75: 643-648
18. Pines J. Cyclins and cyclin-dependent kinases: Take your partners. Trends Biochem Sci 1993; 18: 195-197
19. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-1065
20. Kondo S, Tanaka Y, Kondo Y, et al. Antisense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation. FASEB J 1998; 12: 801-811
21. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825
22. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59-66
23. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78: 67-74
24. Serrano M, Hannon G, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-707
25. Kranenburg O, Scharnhorst V, Van der Eb AJ, et al. Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma. J Cell Biol 1995; 131: 227-234
26. Ito N, Sawa H, Nagane M, et al. Inhibitory effects of sodium butyrate on proliferation and invasiveness of human glioma lines. Neurosurgery 2001; 49: 430-437
27. Vertosick FT, Selker RG, Arena VC. Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography. Neurosurgery 1991; 28: 496-501
28. Li XN, Du ZW, Huang Q, et al. Growth-inhibitory and differentiation-inducing activity of dimethylformamide in cultured human malignant glioma cells. Neurosurgery 1997; 40: 1250-1259
29. Malone C, Schiltz PM, Nayak SK, et al. Combination interferon-alpha2a and 13-cis-retinoic acid enhances radiosensitization of human malignant glioma cells in vitro. Clin Cancer Res 1999; 5: 417-423
30. Borden EC, Lontan R, Levens D, et al. Differentiation therapy of cancer: Laboratory and clinical investigations. Cancer Res 1993; 53: 4109-4115
31. Szeifert GT, Massager N, Brotchi J, et al. Morphological redifferentiation in a malignant astrocytic tumor after gamma knife radiosurgery. J Neurosurg 2002; 97: 627-630